| |
Median
|
Range
|
|---|
|
Age
|
62.6 years
|
35.3 - 77.9 years
|
|
Time to SIRT after primary diagnosis
|
25 months
|
6-140
|
| |
Number
|
Percentage (%)
|
|
Patients
|
49
|
100
|
|
Gender
| | |
|
Female
|
16
|
32.7
|
|
Male
|
33
|
67.3
|
|
Localisation of primary tumor
| | |
|
Colon
|
11
|
22.5
|
|
Sigma
|
22
|
44.0
|
|
Rectum
|
16
|
32.5
|
|
Chemotherapies before SIRT
| | |
|
FOLFOX
|
42
|
85.7
|
|
FOLFIRI
|
47
|
95.9
|
|
Therapy response
| | |
|
REM
|
9
|
18.4
|
|
SD
|
5
|
10.2
|
|
PD
|
35
|
71.4
|
|
Progression defining
| | |
|
liver metastases
|
19
|
54.3
|
|
extrahepatic manifestation
|
6
|
17.1
|
|
deceased
|
10
|
28.6
|
|
One year survival*
| | |
|
Yes
|
22
|
45.8
|
|
No
|
26
|
54.2
|
| |
Median
|
95% Conf. Interval
|
|
Overall survival
|
8.8 months
|
5.1-18.1
|
- * one patient lost to follow-up
